CUI: |
C0030193 |
Disease: |
Pain
|
Pain
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
1554
|
196
|
0.060 |
None |
1.000 |
6 |
|
2014 |
2020 |
Nausea
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
161
|
14
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2020 |
Cachexia
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
273
|
11
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
CUI: |
C0015967 |
Disease: |
Fever
|
Fever
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
1021
|
66
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Polyuria
|
phenotype |
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Sign or Symptom
|
73
|
3
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Seizures
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
2152
|
553
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Burning sensation
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
30
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Dryness of eye
|
phenotype |
Eye Diseases
|
Sign or Symptom
|
149
|
1
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Anxiety symptoms
|
phenotype |
|
Sign or Symptom
|
110
|
10
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Anticipatory nausea
|
phenotype |
|
Sign or Symptom
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Inflammation
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
467
|
|
0.310 |
None |
1.000 |
2 |
|
2004 |
2011 |
Insulin Resistance
|
phenotype |
Nutritional and Metabolic Diseases
|
Pathologic Function
|
162
|
53
|
0.300 |
None |
1.000 |
2 |
|
2005 |
2011 |
Insulin Sensitivity
|
phenotype |
Nutritional and Metabolic Diseases
|
Pathologic Function
|
62
|
|
0.300 |
None |
1.000 |
2 |
|
2005 |
2011 |
Myocardial Reperfusion Injury
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Pathologic Function
|
226
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Adverse reaction to drug
|
group |
Chemically-Induced Disorders
|
Pathologic Function
|
87
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Dyslipoproteinemias
|
phenotype |
Nutritional and Metabolic Diseases
|
Pathologic Function
|
24
|
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Cardiac Hypertrophy
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Pathologic Function
|
88
|
11
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Infection
|
group |
Infections
|
Pathologic Function
|
491
|
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Body Height
|
phenotype |
|
Organism Attribute
|
1903
|
3972
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Mammary Neoplasms, Experimental
|
phenotype |
Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
218
|
|
0.300 |
None |
1.000 |
1 |
|
2000 |
2000 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.400 |
None |
0.938 |
32 |
|
2000 |
2019 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5725
|
942
|
0.300 |
None |
1.000 |
23 |
1
|
2003 |
2019 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.400 |
None |
0.947 |
19 |
1
|
2003 |
2020 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.100 |
None |
0.947 |
19 |
|
2000 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
0.941 |
17 |
1
|
2003 |
2020 |